HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bundled postconditioning therapies improve hemodynamics and neurologic recovery after 17 min of untreated cardiac arrest.

AbstractOBJECTIVE:
Ischemic postconditioning (stutter CPR) and sevoflurane have been shown to mitigate the effects of reperfusion injury in cardiac tissue after 15min of ventricular fibrillation (VF) cardiac arrest. Poloxamer 188 (P188) has also proven beneficial to neuronal and cardiac tissue during reperfusion injury in human and animal models. We hypothesized that the use of stutter CPR, sevoflurane, and P188 combined with standard advanced life support would improve post-resuscitation cardiac and neurologic function after prolonged VF arrest.
METHODS:
Following 17min of untreated VF, 20 pigs were randomized to Control treatment with active compression/decompression (ACD) CPR and impedance threshold device (ITD) (n=8) or Bundle therapy with stutter ACD CPR+ITD+sevoflurane+P188 (n=12). Epinephrine and post-resuscitation hypothermia were given in both groups per standard protocol. Animals that achieved return of spontaneous circulation (ROSC) were evaluated with echocardiography, biomarkers, and a blinded neurologic assessment with a cerebral performance category score.
RESULTS:
Bundle therapy improved hemodynamics during resuscitation, reduced need for epinephrine and repeated defibrillation, reduced biomarkers of cardiac injury and end-organ dysfunction, and increased left ventricular ejection fraction compared to Controls. Bundle therapy also improved rates of ROSC (100% vs. 50%), freedom from major adverse events (50% vs. 0% at 48h), and neurologic function (42% with mild or no neurologic deficit and 17% achieving normal function at 48h).
CONCLUSIONS:
Bundle therapy with a combination of stutter ACD CPR, ITD, sevoflurane, and P188 improved cardiac and neurologic function after 17min of untreated cardiac arrest in pigs. All studies were performed with approval from the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation (protocol #12-11).
AuthorsJason A Bartos, Timothy R Matsuura, Mohammad Sarraf, Scott T Youngquist, Scott H McKnite, Jennifer N Rees, Daniel T Sloper, Frank S Bates, Nicolas Segal, Guillaume Debaty, Keith G Lurie, Robert W Neumar, Joseph M Metzger, Matthias L Riess, Demetris Yannopoulos
JournalResuscitation (Resuscitation) Vol. 87 Pg. 7-13 (Feb 2015) ISSN: 1873-1570 [Electronic] Ireland
PMID25447036 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Anesthetics, Inhalation
  • Methyl Ethers
  • Sevoflurane
Topics
  • Anesthetics, Inhalation (pharmacology)
  • Animals
  • Cardiopulmonary Resuscitation (adverse effects, methods)
  • Coronary Circulation
  • Disease Models, Animal
  • Female
  • Heart (physiopathology)
  • Heart Arrest (etiology, therapy)
  • Hemodynamics
  • Humans
  • Ischemic Postconditioning (methods)
  • Male
  • Methyl Ethers (pharmacology)
  • Myocardial Reperfusion Injury (prevention & control)
  • Neurologic Examination
  • Sevoflurane
  • Stroke Volume
  • Swine
  • Time Factors
  • Treatment Outcome
  • Ventricular Fibrillation (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: